Search

Now showing items 1-9 of 9

Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

SMYTH, PAUL; MARTIN, CARA; MCINERNEY, JAMIE KEVIN; ELBARUNI, SALAH AMRU; O'LEARY, JOHN; SALLEY, YVONNE; VENCKEN, SEBASTIAN; O'TOOLE, SHARON; AHERNE, SINEAD; SHEILS, ORLA; GALLAGHER, MICHAEL (2009)

Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer

SHEILS, ORLA; O'LEARY, JOHN; GALLAGHER, MICHAEL; SPILLANE, CATHY (2015)

Catching Moving Targets: Cancer Stem Cell Targets, Therapy-Resistance & Considerations for Clinical Targeting

GALLAGHER, MICHAEL (2017)

The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.

MARTIN, CARA; SHEILS, ORLA; SMYTH, PAUL; FINN, STEPHEN; O'LEARY, JOHN; GALLAGHER, MICHAEL; BATES, MARK; SPILLANE, CATHY (2014)

CD10-/ALDH- cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell network. Cell Death & Disease

GALLAGHER, MICHAEL; O'TOOLE, SHARON; BATES, MARK (2017)

Targeting aldehyde dehygrogenase 1 (ALDH1) to circumvent cisplatin resistance in NSCLC

GALLAGHER, MICHAEL (2017)

Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

GALLAGHER, MICHAEL; FLAVIN, RICHARD JOHN; SMYTH, PAUL (2009)

An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines.

SHEILS, ORLA; O'LEARY, JOHN; GALLAGHER, MICHAEL; SPILLANE, CATHY (2014)

microRNA-17 is downregulated in esophageal adenocarcinoma cancer stem cells and promotes a radioresistant phenotype

GALLAGHER, MICHAEL (2017)

Browse

All of TARA

This Academic/Research Unit

Discover

Author

Subject

Date Issued

Sponsor

Search

Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer

Catching Moving Targets: Cancer Stem Cell Targets, Therapy-Resistance & Considerations for Clinical Targeting

The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.

CD10-/ALDH- cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell network. Cell Death & Disease

Targeting aldehyde dehygrogenase 1 (ALDH1) to circumvent cisplatin resistance in NSCLC

Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines.

microRNA-17 is downregulated in esophageal adenocarcinoma cancer stem cells and promotes a radioresistant phenotype

Browse

All of TARA

This Academic/Research Unit

Discover

Author

Subject

Date Issued

Sponsor

Search

Advanced Search

Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer

Catching Moving Targets: Cancer Stem Cell Targets, Therapy-Resistance & Considerations for Clinical Targeting

The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.

CD10-/ALDH- cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell network. Cell Death & Disease

Targeting aldehyde dehygrogenase 1 (ALDH1) to circumvent cisplatin resistance in NSCLC

Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines.

microRNA-17 is downregulated in esophageal adenocarcinoma cancer stem cells and promotes a radioresistant phenotype